Unique ID issued by UMIN | UMIN000050411 |
---|---|
Receipt number | R000057395 |
Scientific Title | Online survey of patients with progressive fibrosing interstitial lung disease (PF-ILD) in Japan - A study of physician and patient experiences and perceptions of the course of treatment from initial symptom onset to the time of the survey - |
Date of disclosure of the study information | 2023/02/22 |
Last modified on | 2023/08/30 20:10:56 |
Online survey of patients with progressive fibrosing interstitial lung disease (PF-ILD) in Japan
- A study of physician and patient experiences and perceptions of the course of treatment from initial symptom onset to the time of the survey -
Online survey of patients with progressive fibrosing interstitial lung disease (PF-ILD) in Japan
- A study of physician and patient experiences and perceptions of the course of treatment from initial symptom onset to the time of the survey -
Online survey of patients with progressive fibrosing interstitial lung disease (PF-ILD) in Japan
- A study of physician and patient experiences and perceptions of the course of treatment from initial symptom onset to the time of the survey -
Online survey of patients with progressive fibrosing interstitial lung disease (PF-ILD) in Japan
Japan |
Progressive fibrosing interstitial lung disease
Pneumology | Clinical immunology |
Others
NO
To determine factors that hinder early diagnosis and early intervention by ascertaining actual conditions such as disease awareness and time to start treatment through a questionnaire survey of patients with progressive fibrosing interstitial lung disease (PF-ILD) and physicians with sufficient experience in treating patients with PF-ILD
Others
Not applicable
1) Information on patient backgrounds, disease, treatment experience and awareness of patients with PF-ILD obtained from the physician questionnaire survey
2) Information on patient backgrounds, disease, treatment experience and perceptions of patients with PF-ILD obtained from the patient questionnaire survey
Observational
18 | years-old | <= |
Not applicable |
Male and Female
<Inclusion criteria for physicians>
1) Physicians who are engaged in medical treatment at medical institutions in Japan
2) Physicians with sufficient experience in treating patients with PF-ILD
3) Physicians who have agreed with the objective of the study and provided informed consent of their own free will by themselves electromagnetically on the website for answering the physician questionnaire and requesting questionnaires to multiple patients
<Inclusion criteria for patients>
1) Patients aged 18 years or older (regardless of gender)
2) Patients with a confirmed diagnosis of PF-ILD and continuing treatment (regardless of whether the patient is an outpatient or inpatient)
3) Patients who have been informed by their physician that they have PF-ILD
4) Patients who can provide information before and after the start of treatment for PF-ILD (within approximately 12 months after the start of treatment for PF-ILD)
5) Patients who can understand Japanese
6) Patients who can access the website and complete the questionnaire
7) Patients who have carefully read the explanatory document regarding this study and have given informed consent of their own free will by themselves electromagnetically on the website to participate in this study
<Exclusion criteria for physicians>
Not applicable
<Exclusion criteria for patients>
1) Patients with a confirmed diagnosis of IPF
120
1st name | Tomoo |
Middle name | |
Last name | Okamura |
Nippon Boehringer Ingelheim Co., Ltd.
Specialty Care Medicine, Medicine Division
141-6017
2-1-1 Osaki, Shinagawa-ku, Tokyo, Japan
03-6417-2444
tomoo.okamura@boehringer-ingelheim.com
1st name | Tomoo |
Middle name | |
Last name | Okamura |
Nippon Boehringer Ingelheim Co., Ltd.
Specialty Care Medicine, Medicine Division
141-6017
2-1-1 Osaki, Shinagawa-ku, Tokyo, Japan
03-6417-2444
tomoo.okamura@boehringer-ingelheim.com
Nippon Boehringer Ingelheim Co., Ltd.
Nippon Boehringer Ingelheim Co., Ltd.
Profit organization
Japan
Takahashi Clinic Ethics Committee
Medicalhat 1F , 5-1-31 ,kitamachi ,iwaya, nada-ku, kobe-shi, Hyogo, Japan
078-882-6432
kishimoto.satoshi@neues.co.jp
NO
2023 | Year | 02 | Month | 22 | Day |
Unpublished
141
Completed
2022 | Year | 12 | Month | 23 | Day |
2023 | Year | 01 | Month | 17 | Day |
2023 | Year | 01 | Month | 17 | Day |
2023 | Year | 05 | Month | 19 | Day |
2023 | Year | 05 | Month | 19 | Day |
2023 | Year | 05 | Month | 24 | Day |
2023 | Year | 08 | Month | 08 | Day |
This study will survey to determine the disease awareness and perception of PF-ILD and the time to initiate treatment on physicians and patients via the Web.
2023 | Year | 02 | Month | 22 | Day |
2023 | Year | 08 | Month | 30 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000057395